|Articles|January 19, 2023
Leveraging efficiency from cell line development to clinical manufacturing of monoclonal antibodies
Author(s)Curia
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How Mitigation and Maintenance Protect Against Future Risk
2
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
3
FAQ: Milestones You May Have Missed in the 2025 Biopharma Pipeline
4
Roche Drives Industry Shift With Three-Year Lymphoma Survival Data
5
